Whitehawk Therapeutics, Inc. (WHWK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $180.57M
Last updated: Nov 17, 2026 at 11:04 AM ET
Whitehawk Therapeutics, Inc. (WHWK) Competitors
The companies most similar to Whitehawk Therapeutics are Protara Therapeutics (TARA), NeOnc Technologies Holdings, Inc. Common Stock (NTHI) and Invivyd (IVVD). By market cap, Whitehawk Therapeutics ranks 6th of the 13 companies on this page; Prelude Therapeutics (PRLD) is the largest at $275.32M.
Peer Comparison
WHWK's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Whitehawk Therapeutics (WHWK) | $180.57M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Protara Therapeutics Inc (TARA) | $155.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | $141.66M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Invivyd Inc. (IVVD) | $171.58M | N/A | 2.9x | -183.9% | N/A | 21.2% | 0.00% |
| Compass Therapeutics Inc. (CMPX) | $139.35M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Foghorn Therapeutics Inc (FHTX) | $124.12M | 40.1x | 1.1x | 8.4% | N/A | 925.0% | 0.00% |
| Rocket Pharmaceuticals Inc (RCKT) | $256.82M | N/A | N/A | 0.0% | -2.3% | 0.0% | 0.00% |
| Humacyte Inc (HUMA) | $155.12M | N/A | 62.6x | 0.0% | -60.5% | 36.5% | 0.00% |
| Inhibikase Therapeutics Inc (IKT) | $213.21M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Prelude Therapeutics Inc (PRLD) | $275.32M | N/A | 16.3x | -269.7% | N/A | 41.0% | 0.00% |
| OUTLOOK THERAPEUTICS INC (OTLK) | $100.54M | N/A | N/A | 0.0% | -776.9% | -99.4% | 0.00% |
| Greenwich Lifesciences Inc (GLSI) | $219.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Keros Therapeutics Inc (KROS) | $202.13M | N/A | 4.9x | -151.4% | N/A | 180.5% | 0.00% |
| Peer median | $163.68M | 40.1x | 4.9x | 0.0% | -60.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Whitehawk Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Protara Therapeutics Inc (TARA) | Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying and promoting transformative therapies for the treatment... | TARA competitors |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy... | NTHI competitors |
| Invivyd Inc. (IVVD) | Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery... | IVVD competitors |
| Compass Therapeutics Inc. (CMPX) | Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple... | CMPX competitors |
| Foghorn Therapeutics Inc (FHTX) | Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs that target genetically determined dependencies within... | FHTX competitors |
| Rocket Pharmaceuticals Inc (RCKT) | Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. | RCKT competitors |
| Humacyte Inc (HUMA) | Humacyte Inc (HUMA) is a groundbreaking biotechnology firm at the forefront of vascular and regenerative medicine... | HUMA competitors |
| Inhibikase Therapeutics Inc (IKT) | Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapies for Parkinson's disease (PD) and related disorders that arise inside... | IKT competitors |
| Prelude Therapeutics Inc (PRLD) | Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized... | PRLD competitors |
| OUTLOOK THERAPEUTICS INC (OTLK) | Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic... | OTLK competitors |
| Greenwich Lifesciences Inc (GLSI) | Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 /... | GLSI competitors |
| Keros Therapeutics Inc (KROS) | Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery... | KROS competitors |
Frequently Asked Questions About WHWK
Who are Whitehawk Therapeutics' main competitors?
The companies most similar to Whitehawk Therapeutics include Protara Therapeutics (TARA), NeOnc Technologies Holdings, Inc. Common Stock (NTHI), Invivyd (IVVD), Compass Therapeutics (CMPX) and Foghorn Therapeutics (FHTX), listed from the closest match.
Who is Whitehawk Therapeutics' biggest competitor?
Prelude Therapeutics (PRLD) is the largest of the similar companies at $275.32M; Protara Therapeutics (TARA) is the closest match by business profile, size, sector and industry.
How does WHWK stock compare with its competitors?
WHWK's net margin is 0.0% against a peer median of 0.0%.
Which of Whitehawk Therapeutics' competitors pays a higher dividend?
Whitehawk Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Whitehawk Therapeutics bigger than its competitors?
No. Whitehawk Therapeutics is 6th by market cap among the 13 companies on this page; the largest is Prelude Therapeutics (PRLD) at $275.32M.
WHWK pages: Overview, Earnings, Forecast, Financials, Competitors